A Green Sign – Lifestyle
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
March 4, 2026
←
Previous Page
1
2
3